Joseph J. Dajcs

756 total citations
24 papers, 622 citations indexed

About

Joseph J. Dajcs is a scholar working on Ophthalmology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Joseph J. Dajcs has authored 24 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 8 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Joseph J. Dajcs's work include Ocular Infections and Treatments (19 papers), Intraocular Surgery and Lenses (12 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Joseph J. Dajcs is often cited by papers focused on Ocular Infections and Treatments (19 papers), Intraocular Surgery and Lenses (12 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Joseph J. Dajcs collaborates with scholars based in United States, Italy and South Korea. Joseph J. Dajcs's co-authors include Richard J. O’Callaghan, Brett A. Thibodeaux, Dalia O. Girgis, David W. Stroman, Emma B.H. Hume, Mary E. Marquart, Judy M. Moreau, Barry A. Schlech, Gregory D. Sloop and Armando R. Caballero and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity and Investigative Ophthalmology & Visual Science.

In The Last Decade

Joseph J. Dajcs

24 papers receiving 606 citations

Peers

Joseph J. Dajcs
A. D. Sawant United States
A W Fothergill United States
David McKenney United States
Astrid Leck United Kingdom
Yefei Zhu United States
Tim Conibear Australia
Ilse Curfs-Breuker Netherlands
A. D. Sawant United States
Joseph J. Dajcs
Citations per year, relative to Joseph J. Dajcs Joseph J. Dajcs (= 1×) peers A. D. Sawant

Countries citing papers authored by Joseph J. Dajcs

Since Specialization
Citations

This map shows the geographic impact of Joseph J. Dajcs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Dajcs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Dajcs more than expected).

Fields of papers citing papers by Joseph J. Dajcs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph J. Dajcs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Dajcs. The network helps show where Joseph J. Dajcs may publish in the future.

Co-authorship network of co-authors of Joseph J. Dajcs

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Dajcs. A scholar is included among the top collaborators of Joseph J. Dajcs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Dajcs. Joseph J. Dajcs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pantůček, Roman, Pavel Švec, Joseph J. Dajcs, et al.. (2013). Staphylococcus petrasii sp. nov. including S. petrasii subsp. petrasii subsp. nov. and S. petrasii subsp. croceilyticus subsp. nov., isolated from human clinical specimens and human ear infections. Systematic and Applied Microbiology. 36(2). 90–95. 25 indexed citations
2.
Thaller, María Cristina, Luisa Borgianni, Gustavo Di Lallo, et al.. (2010). Metallo-β-Lactamase Production by Pseudomonas otitidis : a Species-Related Trait. Antimicrobial Agents and Chemotherapy. 55(1). 118–123. 33 indexed citations
3.
Therese, K. Lily, et al.. (2009). DNA sequencing by Microseq kit targeting 16S rRNA gene for species level identification of mycobacteria.. PubMed. 129(2). 176–81. 9 indexed citations
4.
Dajcs, Joseph J., et al.. (2006). The Effectiveness of Lysostaphin Therapy for Experimental Coagulase-NegativeStaphylococcusEndophthalmitis. Current Eye Research. 31(3). 225–230. 8 indexed citations
5.
Thibodeaux, Brett A., Armando R. Caballero, Joseph J. Dajcs, et al.. (2005). Pseudomonas aeruginosaProtease IV: A Corneal Virulence Factor of Low Immunogenicity. Ocular Immunology and Inflammation. 13(2-3). 169–182. 13 indexed citations
6.
Stroman, David W., et al.. (2005). In Vitro and In Vivo Potency of Moxifloxacin and Moxifloxacin Ophthalmic Solution 0.5%, A New Topical Fluoroquinolone. Survey of Ophthalmology. 50(6). S16–S31. 65 indexed citations
7.
Girgis, Dalia O., et al.. (2005). Pathogenesis ofStaphylococcusin the Rabbit Anterior Chamber. Investigative Ophthalmology & Visual Science. 46(4). 1371–1371. 10 indexed citations
8.
Thibodeaux, Brett A., Joseph J. Dajcs, Armando R. Caballero, et al.. (2004). Quantitative comparison of fluoroquinolone therapies of experimental Gram-negative bacterial keratitis. Current Eye Research. 28(5). 337–342. 22 indexed citations
9.
Dajcs, Joseph J., et al.. (2004). Effectiveness of Ciprofloxacin, Levofloxacin, or Moxifloxacin for Treatment of Experimental Staphylococcus aureus Keratitis. Antimicrobial Agents and Chemotherapy. 48(6). 1948–1952. 57 indexed citations
10.
Marquart, Mary E., Joseph J. Dajcs, Armando R. Caballero, Brett A. Thibodeaux, & Richard J. O’Callaghan. (2003). Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor. Medical Microbiology and Immunology. 194(1-2). 39–45. 18 indexed citations
11.
Girgis, Dalia O., Joseph J. Dajcs, & Richard J. O’Callaghan. (2003). Phospholipase A2Activity in Normal andStaphylococcus aureus-Infected Rabbit Eyes. Investigative Ophthalmology & Visual Science. 44(1). 197–197. 18 indexed citations
12.
Dajcs, Joseph J., Brett A. Thibodeaux, Dalia O. Girgis, & Richard J. O’Callaghan. (2002). Corneal Virulence of Staphylococcus aureus in an Experimental Model of Keratitis. DNA and Cell Biology. 21(5-6). 375–382. 46 indexed citations
13.
Moreau, Judy M., Emma B.H. Hume, Joseph J. Dajcs, et al.. (2002). Effectiveness of Mupirocin and Polymyxin B in Experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens Keratitis. Cornea. 21(8). 807–811. 15 indexed citations
14.
Dajcs, Joseph J., Gregory D. Sloop, Judy M. Moreau, et al.. (2002). Corneal pathogenesis of Staphylococcus aureus strain Newman.. PubMed. 43(4). 1109–15. 40 indexed citations
15.
Dajcs, Joseph J., et al.. (2002). Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.. PubMed. 43(12). 3712–6. 41 indexed citations
16.
Dajcs, Joseph J., Judy M. Moreau, David W. Stroman, et al.. (2001). The effectiveness of tobramycin and Ocuflox® in a prophylaxis model of Staphylococcus keratitis. Current Eye Research. 23(1). 60–63. 9 indexed citations
17.
Dajcs, Joseph J., Brett A. Thibodeaux, Emma B.H. Hume, et al.. (2001). Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Current Eye Research. 22(6). 451–457. 38 indexed citations
18.
Dajcs, Joseph J., Judy M. Moreau, Brett A. Thibodeaux, et al.. (2001). Effectiveness of Ciprofloxacin and Ofloxacin in a Prophylaxis Model of Staphylococcus Keratitis. Cornea. 20(8). 878–880. 8 indexed citations
19.
Hume, Emma B.H., Joseph J. Dajcs, Judy M. Moreau, & Richard J. O’Callaghan. (2000). Immunization with Alpha-Toxin Toxoid Protects the Cornea against Tissue Damage during Experimental Staphylococcus aureus Keratitis. Infection and Immunity. 68(10). 6052–6055. 43 indexed citations
20.
Hume, Emma B.H., et al.. (1999). Clarithromycin for experimental Staphylococcus aureus keratitis. Current Eye Research. 18(5). 358–362. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026